These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 3105451

  • 1. In vitro activity of CGP 31608, a new penem.
    Wise R, Andrews JM, Piddock LJ.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
    Wise R, Cross C, Andrews JM.
    Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
    [Abstract] [Full Text] [Related]

  • 3. Review of the in vitro spectrum of activity of imipenem.
    Jones RN.
    Am J Med; 1985 Jun 07; 78(6A):22-32. PubMed ID: 3890537
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activity of CGP 31608, a new penem antibiotic.
    Eliopoulos GM, Wennersten C, Reiszner E, Moellering RC.
    Antimicrob Agents Chemother; 1987 Aug 07; 31(8):1188-93. PubMed ID: 3498437
    [Abstract] [Full Text] [Related]

  • 5. [In vitro antibacterial activity of a new parenteral penem, sulopenem].
    Yoshida T, Tateda E, Hiramatsu K, Yokota T.
    Jpn J Antibiot; 1996 Apr 07; 49(4):324-37. PubMed ID: 8786624
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC, Chin NX, Neu NM.
    Antimicrob Agents Chemother; 1987 Apr 07; 31(4):558-69. PubMed ID: 3496845
    [Abstract] [Full Text] [Related]

  • 7. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
    Schrinner E, Limbert M, Seeger K, Seibert G, Novick WJ.
    Diagn Microbiol Infect Dis; 1984 Jun 07; 2(3 Suppl):13S-20S. PubMed ID: 6086214
    [Abstract] [Full Text] [Related]

  • 8. Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
    Bauernfeind A.
    J Antimicrob Chemother; 1985 Jun 07; 15 Suppl C():155-64. PubMed ID: 3897170
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of CP-65,207, a new penem antimicrobial agent, in comparison with those of other agents.
    Gootz T, Retsema J, Girard A, Hamanaka E, Anderson M, Sokolowski S.
    Antimicrob Agents Chemother; 1989 Aug 07; 33(8):1160-6. PubMed ID: 2679370
    [Abstract] [Full Text] [Related]

  • 10. Interaction of the novel penem CGP 31 608 and its enantiomer with type Id beta-lactamase and penicillin-binding proteins.
    Mett H, Schacher B, Schneider P, Zak O.
    Eur J Clin Microbiol; 1987 Dec 07; 6(6):674-8. PubMed ID: 3126060
    [Abstract] [Full Text] [Related]

  • 11. Comparison of in vitro activity of FCE 22101, a new penem, with those of other beta-lactam antibiotics.
    Wise R, Andrews JM, Danks G.
    Antimicrob Agents Chemother; 1983 Dec 07; 24(6):909-14. PubMed ID: 6607032
    [Abstract] [Full Text] [Related]

  • 12. The antimicrobial activity of cefpirome, a new cephalosporin.
    Wise R, Andrews JM, Cross C, Piddock LJ.
    J Antimicrob Chemother; 1985 Apr 07; 15(4):449-56. PubMed ID: 3874198
    [Abstract] [Full Text] [Related]

  • 13. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
    Fontana R, Altamura M, Arcamone F, Mazzariol A, Morandotti G, Sperning R, Cornaglia G.
    J Antimicrob Chemother; 1998 May 07; 41(5):513-25. PubMed ID: 9630405
    [Abstract] [Full Text] [Related]

  • 14. In vitro antibacterial activity of LJC 11,036, an active metabolite of L-084, a new oral carbapenem antibiotic with potent antipneumococcal activity.
    Hikida M, Itahashi K, Igarashi A, Shiba T, Kitamura M.
    Antimicrob Agents Chemother; 1999 Aug 07; 43(8):2010-6. PubMed ID: 10428928
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
    Fukuoka T, Ohya S, Utsui Y, Domon H, Takenouchi T, Koga T, Masuda N, Kawada H, Kakuta M, Kubota M, Ishii C, Ishii C, Sakagawa E, Harasaki T, Hirasawa A, Abe T, Yasuda H, Iwata M, Kuwahara S.
    Antimicrob Agents Chemother; 1997 Dec 07; 41(12):2652-63. PubMed ID: 9420035
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
    Ubukata K, Hikida M, Yoshida M, Nishiki K, Furukawa Y, Tashiro K, Konno M, Mitsuhashi S.
    Antimicrob Agents Chemother; 1990 Jun 07; 34(6):994-1000. PubMed ID: 2203313
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M, Sekine Y, Shimizu S, Takano H, Angehrn P, Then RL.
    Antimicrob Agents Chemother; 1991 Apr 07; 35(4):653-9. PubMed ID: 1906261
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Nagano R, Shibata K, Adachi Y, Imamura H, Hashizume T, Morishima H.
    Antimicrob Agents Chemother; 2000 Mar 07; 44(3):489-95. PubMed ID: 10681308
    [Abstract] [Full Text] [Related]

  • 19. In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams.
    Watanabe Y, Minami S, Hayashi T, Araki H, Kitayama R, Ochiai H.
    Antimicrob Agents Chemother; 1995 Dec 07; 39(12):2787-91. PubMed ID: 8593021
    [Abstract] [Full Text] [Related]

  • 20. The antimicrobial activity of cephalexin against old and new pathogens.
    Jones RN, Preston DA.
    Postgrad Med J; 1983 Dec 07; 59 Suppl 5():9-15. PubMed ID: 6364091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.